Hims AI Market Strategy Report - Hair Loss Treatments

Answer Capsule

Hims holds a moderate position in AI-driven hair loss treatment discovery with a monthly AI Authority Value of $1.0M, but it is significantly outperformed by Nutrafol, Rogaine, and Keeps across all high-intent prompt clusters. The benchmark shows Hims achieves a 9.7% Top 10 recommendation rate and a 9.4% Top 3 rate, placing it in a middle tier behind the category leaders. Hims performs best on Google AI Mode, where it captures 5.1% of the platform opportunity, but its recommendation coverage lags behind competitors with stronger clinical citation architecture. The clearest opportunity for Hims is converting its solid presence rate of 15.9% into higher recommendation-stage visibility, particularly in the evaluation and decision clusters where it is currently displaced by Nutrafol and Rogaine.

Who This Report Is For

This report is for marketing, brand strategy, and growth leaders at Hims who need to understand how AI platforms are shaping consumer discovery and shortlist formation in the hair loss treatment category.

Report Card

• Report type: AI Company Market Strategy Report
• Target company: Hims
• Category / market studied: Hair Loss Treatments
• Reporting month: June 2026
• AI platforms tracked: ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity
• Public high-intent clusters: 3 (Best Telehealth & Online Prescription Services, Telehealth Platform Comparisons, Telehealth & Online Prescription Pricing)
• AI observations analyzed: 1,102
• Competitors tracked: Nutrafol, Rogaine, Keeps, Happy Head, Bosley, HairClub, Ro (Roman), Folexin, Propecia (Merck)

Executive Summary

Hims appears in 15.9% of all AI observations across the hair loss treatment category, giving it a solid baseline of brand awareness among AI systems. However, the benchmark reveals a meaningful gap between presence and recommendation power. Hims receives valid recommendations in only 10.3% of observations, and its Top 3 recommendation rate of 9.4% places it behind Nutrafol (19.1%), Rogaine (16.6%), and Happy Head (9.2%).

The strongest signal for Hims is in the pricing cluster, where it achieves a 14.9% Top 10 rate and an average recommended rank of 1.82. This cluster carries the highest buyer-stage multiplier and represents the moment when consumers are ready to purchase. Hims captures $425K in AI Authority Value in this cluster, its strongest individual cluster performance.

The weakest signal is in the consideration cluster, where Hims achieves only a 7.5% Top 10 rate and a 7.2% Top 3 rate. In this initial discovery phase, Hims is being outperformed by Keeps, which leads the cluster with $1.4M in captured value, and by Nutrafol and Rogaine.

Platform performance varies significantly. Hims performs best on Google AI Mode with a 16.4% Top 10 rate and a 16.4% positive visibility rate. On ChatGPT, Hims achieves only a 3.4% Top 10 rate and a net sentiment score of 0.33, its weakest platform performance. On Perplexity, Hims captures $389K in AI Authority Value, but most of this comes from visibility assist rather than direct recommendations.

Hims has a net sentiment score of 0.70, indicating that when it appears in AI responses, the framing is generally positive. This is a stronger sentiment position than Nutrafol (0.57) and comparable to Rogaine (0.69). However, positive sentiment without recommendation conversion limits commercial impact.

What Hims Is Winning

Strongest cluster: Pricing and decision. In the Telehealth & Online Prescription Pricing cluster, Hims achieves a 14.9% Top 10 rate and a 14.1% Top 3 rate, its highest recommendation performance across all clusters. The average recommended rank of 1.82 in this cluster is strong, meaning that when Hims is recommended, it appears near the top of the shortlist. This cluster carries the highest buyer-stage multiplier at 1.5x, making it the most commercially valuable cluster for Hims.

Strongest platform: Google AI Mode. Hims achieves its highest recommendation coverage on Google AI Mode with a 16.4% Top 10 rate and a 16.4% positive visibility rate. The average recommended rank on this platform is 1.64, and Hims captures $328K in AI Authority Value. This is the only platform where Hims breaks into double-digit recommendation coverage.

Strongest sentiment: Google AI Overviews. Hims achieves a net sentiment score of 0.86 on Google AI Overviews, its highest platform-level sentiment. This indicates that when Hims appears in AI Overviews responses, the framing is strongly positive. However, the recommendation coverage on this platform is 13.6%, meaning positive sentiment is not translating into recommendation conversion at the same rate as competitors.

Average recommended rank. Hims holds an average recommended rank of 1.67 across all platforms, which is competitive with Rogaine (1.58) and better than Nutrafol (2.24) and Keeps (2.13). When Hims is recommended, it tends to appear in the first or second position, suggesting that the brand has strong trust signals for the AI systems that do choose to recommend it.

Where Hims Has the Clearest AI Visibility Gaps

Weak recommendation conversion in the consideration cluster. In the Best Telehealth & Online Prescription Services cluster, Hims achieves only a 7.5% Top 10 rate and a 7.2% Top 3 rate. This is the initial discovery phase where consumers are first learning about treatment options. Keeps leads this cluster with $1.4M in captured value, and Nutrafol and Rogaine also outperform Hims significantly. Hims is present in 14.2% of observations in this cluster but converts only a fraction of that presence into recommendations.

ChatGPT underperformance. On ChatGPT, Hims achieves only a 3.4% Top 10 rate and a 3.4% positive visibility rate. The net sentiment score on ChatGPT is 0.33, the lowest of any platform. Rogaine dominates ChatGPT with a 25.7% recommendation coverage and a 25.1% rank-one rate. Hims captures only $4K in AI Authority Value on ChatGPT, compared to $485K for Rogaine. This is the clearest platform-level gap in the dataset.

Displacement by Nutrafol and Rogaine in evaluation. In the Telehealth Platform Comparisons cluster, Hims achieves a 6.5% Top 10 rate and a 6.5% Top 3 rate. Rogaine dominates this cluster with a 24.8% Top 10 rate and a 24.5% Top 3 rate. Nutrafol follows at 19.4% Top 10. Hims is being displaced in the evaluation stage, where consumers are actively comparing treatment options and providers.

Low rank-one rate. Hims achieves a rank-one rate of 4.6% across all platforms, compared to Rogaine's 14.2% and Nutrafol's 8.7%. This means Hims is rarely the first choice presented by AI systems. Even when Hims is recommended, it is typically the second or third option, which reduces its share of buyer attention.

Perplexity visibility without recommendation conversion. On Perplexity, Hims captures $389K in AI Authority Value, but $349K of that comes from visibility assist rather than direct recommendations. The recommendation coverage on Perplexity is only 8.6%, meaning Hims appears frequently but is not being advanced as a top choice. This pattern suggests that Hims has source material that Perplexity retrieves but does not find compelling enough to recommend.

Biggest Opportunity

Convert pricing cluster strength into broader recommendation coverage. Hims performs best in the pricing and decision cluster, where it achieves a 14.9% Top 10 rate and a strong average rank of 1.82. This cluster represents the highest-intent buying moment, and Hims is already competitive here. The opportunity is to extend this recommendation performance into the consideration and evaluation clusters, where Hims currently underperforms. If Hims can match its pricing cluster recommendation rates in the consideration cluster, the estimated increase in AI Authority Value would be significant. This requires strengthening the public evidence layer that AI systems use to evaluate and recommend brands in the early discovery and comparison stages.

Prompt Evidence

Google AI Mode / Pricing (Decision) Prompt: "Compare pricing for telehealth hair loss treatments" Result: Hims appeared in the Top 3 recommendations with an average rank of 1.64, its strongest recommendation performance across all platforms and clusters.

ChatGPT / Evaluation (Comparison) Prompt: "Which telehealth platform is best for hair loss treatment?" Result: Hims appeared in only 3.4% of observations with a net sentiment score of 0.33, significantly underperforming Rogaine and Nutrafol on this platform.

Google AI Overviews / Consideration (Discovery) Prompt: "What are the best online hair loss treatment services?" Result: Hims achieved a 13.6% Top 10 rate with a net sentiment score of 0.86, indicating positive framing but limited recommendation conversion relative to category leaders.

Perplexity / Pricing (Decision) Prompt: "How much do hair loss treatments cost online?" Result: Hims appeared in 16.1% of observations but received valid recommendations in only 8.6% of cases, with most captured value coming from visibility assist rather than direct recommendation credit.

What CiteWorks Studio Would Do Next

Phase 1: AI Market Discovery Audit. Map the full prompt landscape across all 10 tracked clusters to identify which specific queries Hims wins, loses, or is displaced on, and which competitors are capturing the most recommendation value in each cluster.

Phase 2: Recommendation Readiness Plan. Analyze the gap between Hims's presence rate and recommendation conversion rate, particularly in the consideration and evaluation clusters, and identify the specific citation and source gaps that prevent AI systems from advancing Hims as a top choice.

Phase 3: Owned Answer Layer Buildout. Develop structured, retrievable content for the comparison and evaluation prompts where Hims is currently displaced, including pricing comparison pages, treatment option guides, and clinical evidence summaries that AI systems can cite.

Phase 4: Citation / Authority Layer Development. Strengthen the public evidence layer with dermatologist review content, clinical study references, and third-party comparison articles that provide the trust signals AI systems use to justify recommendations.

Phase 5: Monthly AI Visibility and Recommendation Tracking. Monitor Hims's recommendation coverage, rank position, and sentiment across all six platforms on a monthly basis to measure the impact of citation and content improvements and identify emerging competitor threats.

Why This Matters

AI platforms are becoming the primary shortlist builder for consumers researching hair loss treatments. When a prospective patient asks for the best treatment option, the brands that appear in the Top 3 recommendations capture the majority of the commercial value. Brands that are merely mentioned without being ranked are effectively invisible in the buying moment.

Hims has a solid presence in AI responses, but presence alone does not drive commercial outcomes. The benchmark shows that Hims is being retrieved by AI systems but is not consistently being advanced as a top choice. The difference between being mentioned and being recommended is the difference between being visible and being chosen. For Hims to capture more of the AI-driven discovery opportunity, the next move is targeted correction of the prompt, page, and citation layers that influence recommendation decisions.

Core Metrics

• Mentions: 175 out of 1,102 observations
• Valid recommendations: 113
• Top 3 recommendation count: 103
• Rank 1 recommendation count: 51
• Average recommended rank: 1.67
• Positive mentions: 123
• Neutral mentions: 51
• Negative mentions: 1
• Raw mention presence rate: 15.9%
• Valid recommendation coverage: 10.3%
• Top 3 recommendation rate: 9.4%
• Rank 1 recommendation rate: 4.6%
• Strongest cluster by recommendation behavior: Telehealth & Online Prescription Pricing (14.9% Top 10 rate)
• Strongest platform by recommendation behavior: Google AI Mode (16.4% Top 10 rate)

Sentiment Score

Sentiment Score = (positive mentions x 1 + neutral mentions x 0 + negative mentions x -1) / total mentions

Hims Sentiment Score = (123 x 1 + 51 x 0 + 1 x -1) / 175 = 122 / 175 = 0.70

This score means that when Hims appears in AI responses, the framing is generally positive. However, unclassified mention counts can be misleading. Share of voice is a diagnostic metric, not a business KPI. A positive recommendation, neutral reference, cautionary mention, and competitor-displaced mention are not equal in commercial weight. Counting all mentions as wins produces a distorted picture of AI discovery performance. Classified sentiment is the required starting point before interpreting what AI visibility actually means for shortlist eligibility. Hims has a strong sentiment position, but that position does not automatically translate into recommendation conversion.

Sentiment by Platform

Methodology

1. This analysis is based on the LLM Authority Index benchmark for the Hair Loss Treatments category, published for June 2026. CiteWorks Studio interprets the benchmark data to produce company-specific market strategy reports.
2. The reporting window is June 2026. Data was collected during this month and reflects AI system behavior at that point in time.
3. Six AI platforms were tracked: ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, and Perplexity.
4. A total of 1,102 observations were analyzed across three public high-intent prompt clusters. The full benchmark includes 10 clusters.
5. The competitor universe includes 10 brands: Nutrafol, Rogaine, Keeps, Hims, Happy Head, Bosley, HairClub, Ro (Roman), Folexin, and Propecia (Merck).
6. Three public high-intent clusters are reported: Best Telehealth & Online Prescription Services (consideration), Telehealth Platform Comparisons (evaluation), and Telehealth & Online Prescription Pricing (decision).
7. Stage 0 refers to the raw observation collection stage, where AI responses are captured and cataloged before any scoring or classification is applied.
8. A mention means the company appeared in an AI-generated response, regardless of sentiment, rank, or recommendation status.
9. A valid recommendation is a positive, shortlist-quality recommendation or ranked recommendation that earns recommendation credit. Visibility is not the same as recommendation credit. This distinction is the basis for all coverage and rate calculations in this report.
10. Limitations: This is a point-in-time benchmark for June 2026. AI outputs can change as models update and source material shifts. Modeled values are estimates and are not revenue figures. This report is not a full audit or full market census. The public version covers 3 of 10 tracked clusters. The remaining clusters may reveal different competitive dynamics not visible in this report.

See How AI Is Recommending Your Brand

The public benchmark shows the market shape for the hair loss treatment category. A company-specific analysis would identify which prompts Hims wins or loses, which AI platforms are under-recognizing the brand relative to its category position, which source layers are shaping current recommendations, and what changes to the citation and content architecture may improve shortlist eligibility. Contact CiteWorks Studio for an AI Visibility Audit that maps your brand's recommendation-stage visibility and identifies the specific gaps competitors are currently exploiting.